Nanophase Technologies Corporation (NANX)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nanophase Technologies Corporation (NANX) with AI Score 51/100 (Hold). Nanophase Technologies Corporation specializes in engineered materials, formulation development, and commercial manufacturing, primarily serving the personal care and industrial coatings sectors. Market cap: 0, Sector: Basic materials.
Last analyzed: Mar 15, 2026Nanophase Technologies Corporation (NANX) Materials & Commodity Exposure
Nanophase Technologies Corporation delivers engineered materials and formulation solutions, focusing on surface-engineered zinc oxide and titanium dioxide for personal care and industrial applications. With a market capitalization of $0.16 billion, the company operates in the specialty chemicals sector, emphasizing innovation in sunscreens, cosmetics, and advanced material products.
Investment Thesis
Nanophase Technologies Corporation presents a focused investment opportunity within the specialty chemicals sector. The company's emphasis on surface-engineered materials, particularly zinc oxide and titanium dioxide, caters to the growing demand for high-performance ingredients in personal care and industrial applications. With a market capitalization of $0.16 billion and a P/E ratio of 62.32, the company's valuation reflects its growth potential. A key value driver is the expansion of the Solésence brand, which offers fully formulated cosmetic and sun care products. The company's gross margin of 24.8% indicates opportunities for improved operational efficiency. Potential investors should monitor the company's ability to scale production and expand its customer base. The company's beta of 1.22 suggests higher volatility compared to the market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.16 billion reflects the company's size and potential within the specialty chemicals market.
- P/E Ratio of 62.32 indicates the price investors are willing to pay for each dollar of earnings, suggesting growth expectations.
- Profit Margin of 1.7% highlights the need for improved operational efficiency and cost management.
- Gross Margin of 24.8% shows the percentage of revenue exceeding the cost of goods sold, indicating pricing strategy and production costs.
- Beta of 1.22 suggests the stock is more volatile than the market, potentially offering higher returns but also greater risk.
Competitors & Peers
Strengths
- Proprietary surface engineering technology.
- Integrated materials and formulation expertise.
- Established Solésence brand in personal care.
- Diverse applications across multiple industries.
Weaknesses
- Small market capitalization.
- Low profit margin.
- Limited brand recognition outside personal care.
- Dependence on key customers.
Catalysts
- Expansion of the Solésence brand into new markets and product categories.
- Increased adoption of zinc oxide and titanium dioxide in sunscreens due to regulatory changes and consumer preferences.
- Penetration of architectural and industrial coatings market with advanced material products.
- Development of new applications in medical diagnostics through strategic partnerships.
- Potential for new contracts with major personal care or industrial companies.
Risks
- Competition from larger chemical companies with greater resources.
- Fluctuations in raw material prices affecting profitability.
- Changes in regulations regarding sunscreen ingredients impacting product formulations.
- Dependence on key customers for a significant portion of revenue.
- Limited liquidity in the OTC market affecting trading efficiency.
Growth Opportunities
- Expansion of Solésence Brand: The Solésence brand, offering fully formulated cosmetics, sun care, and skin care products, presents a significant growth opportunity. The global cosmetics market is projected to reach $463.5 billion by 2027, driven by increasing consumer demand for high-quality and innovative products. Nanophase can leverage its expertise in surface-engineered materials to develop unique formulations and expand its market share. Timeline: Ongoing.
- Increased Adoption of Zinc Oxide and Titanium Dioxide in Sunscreens: The demand for zinc oxide and titanium dioxide in sunscreens is growing due to their safety and effectiveness as UV filters. The global sunscreen market is expected to reach $16.7 billion by 2028. Nanophase can capitalize on this trend by increasing its production capacity and expanding its customer base. Timeline: Ongoing.
- Penetration of Architectural and Industrial Coatings Market: Nanophase's advanced material products, such as architectural and industrial coatings, offer growth potential in the construction and manufacturing sectors. The global coatings market is projected to reach $175.26 billion by 2029, driven by increasing infrastructure development and industrial activity. Nanophase can leverage its expertise in surface finishing technologies to develop high-performance coatings that meet specific customer needs. Timeline: Ongoing.
- Development of New Applications in Medical Diagnostics: Nanophase's materials have potential applications in medical diagnostics, such as contrast agents and drug delivery systems. The global medical diagnostics market is expected to reach $112.7 billion by 2025, driven by increasing demand for early and accurate disease detection. Nanophase can collaborate with medical device companies to develop innovative diagnostic solutions. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Nanophase can pursue strategic partnerships and acquisitions to expand its product portfolio, market reach, and technological capabilities. Collaborating with complementary businesses can accelerate innovation and enhance the company's competitive position. Timeline: Ongoing.
Opportunities
- Expansion of Solésence brand into new markets.
- Increased adoption of zinc oxide and titanium dioxide in sunscreens.
- Penetration of architectural and industrial coatings market.
- Development of new applications in medical diagnostics.
Threats
- Competition from larger chemical companies.
- Fluctuations in raw material prices.
- Changes in regulations regarding sunscreen ingredients.
- Economic downturn affecting demand for industrial coatings.
Competitive Advantages
- Proprietary surface engineering technology.
- Integrated approach combining materials and formulation expertise.
- Established relationships with key customers.
- Solésence brand recognition in the personal care market.
About NANX
Nanophase Technologies Corporation, established in 1989 and headquartered in Romeoville, Illinois, is a provider of engineered materials, formulation development, and commercial manufacturing services. The company's core business revolves around an integrated family of technologies that cater to various industries. Nanophase is known for its surface-engineered zinc oxide and titanium dioxide, which are key ingredients in sunscreens and personal care products. These materials are marketed under the Solésence brand, which includes fully formulated cosmetics, sun care, and skin care products. Beyond personal care, Nanophase also offers advanced material products for architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and surface finishing applications. The company's integrated approach allows it to offer customized solutions and high-performance materials to meet specific customer needs. With a team of 79 employees, Nanophase focuses on innovation and quality in the specialty chemicals market. The company's evolution has been marked by a commitment to developing advanced materials that enhance product performance and sustainability.
What They Do
- Develops and manufactures engineered materials.
- Provides formulation development services.
- Offers commercial manufacturing solutions.
- Produces surface-engineered zinc oxide for sunscreens.
- Creates surface-engineered titanium dioxide for personal care products.
- Markets fully formulated cosmetics under the Solésence brand.
- Supplies advanced materials for industrial coatings.
- Offers abrasion-resistant additives for various applications.
Business Model
- Develops and sells engineered materials to manufacturers.
- Provides formulation development services to create custom solutions.
- Manufactures and sells fully formulated products under the Solésence brand.
- Generates revenue through direct sales and distribution partnerships.
Industry Context
Nanophase Technologies Corporation operates in the specialty chemicals industry, which is characterized by innovation and customized solutions. The market is driven by demand for high-performance materials in personal care, coatings, and other applications. The competitive landscape includes companies like ADVZF (Advanced Materials Technologies Inc.) and HERC (Hercules Capital Inc.), each with its own focus and strengths. Nanophase differentiates itself through its integrated approach, offering both engineered materials and formulation development services. The specialty chemicals market is expected to grow, driven by increasing demand for advanced materials and sustainable solutions.
Key Customers
- Personal care product manufacturers.
- Cosmetics companies.
- Sunscreen brands.
- Industrial coating companies.
- Medical device manufacturers.
Financials
Chart & Info
Nanophase Technologies Corporation (NANX) stock price: Price data unavailable
Latest News
No recent news available for NANX.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NANX.
Price Targets
Wall Street price target analysis for NANX.
MoonshotScore
What does this score mean?
The MoonshotScore rates NANX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Kevin Cureton
CEO
Kevin Cureton serves as the CEO of Nanophase Technologies Corporation, leading a team of 79 employees. His background includes extensive experience in the specialty chemicals and materials science industries. Prior to joining Nanophase, Cureton held leadership positions at various companies, focusing on strategic planning, product development, and market expansion. He has a proven track record of driving growth and innovation in technology-driven organizations. Cureton's expertise spans across multiple disciplines, including engineering, manufacturing, and sales.
Track Record: Under Kevin Cureton's leadership, Nanophase Technologies Corporation has focused on expanding its Solésence brand and penetrating new markets. He has overseen the development of innovative formulations and the implementation of strategic partnerships. Cureton has also emphasized operational efficiency and cost management to improve the company's profitability. His tenure has been marked by a commitment to sustainable solutions and high-performance materials.
NANX OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Nanophase Technologies Corporation may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited reporting requirements and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. This tier typically involves higher risks due to the potential for less transparency and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Lower liquidity compared to major exchanges.
- Higher price volatility.
- Potential for fraud or manipulation.
- Less regulatory oversight.
- Verify the company's financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory filings.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Check for any red flags or warning signs.
- Long operating history since 1989.
- Focus on engineered materials and formulation development.
- Presence in the personal care and industrial coatings markets.
- Solésence brand recognition.
- Team of 79 employees.
Nanophase Technologies Corporation Basic Materials Stock: Key Questions Answered
What does Nanophase Technologies Corporation do?
Nanophase Technologies Corporation specializes in the development, manufacturing, and commercialization of engineered materials and formulation solutions. The company's core products include surface-engineered zinc oxide and titanium dioxide, which are used in sunscreens, personal care products, and industrial coatings. Nanophase also offers fully formulated cosmetics and sun care products under the Solésence brand. The company operates in the specialty chemicals sector, providing customized solutions to meet specific customer needs. Their integrated approach combines materials science expertise with formulation development and commercial manufacturing capabilities.
What do analysts say about NANX stock?
AI analysis is currently pending for NANX. Generally, analysts covering companies in the specialty chemicals sector focus on factors such as revenue growth, gross margin, and market share. Key valuation metrics include the price-to-earnings ratio (P/E) and enterprise value-to-EBITDA (EV/EBITDA). Growth considerations often revolve around the company's ability to expand its product portfolio, penetrate new markets, and maintain a competitive advantage through innovation and strategic partnerships. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions.
What are the main risks for NANX?
Nanophase Technologies Corporation faces several risks inherent to its business and industry. Competition from larger chemical companies with greater resources poses a significant threat. Fluctuations in raw material prices can impact the company's profitability. Changes in regulations regarding sunscreen ingredients could require reformulation of existing products. Dependence on key customers for a significant portion of revenue creates concentration risk. Additionally, the limited liquidity in the OTC market can affect trading efficiency and price volatility. Investors should carefully consider these risks before investing in NANX.
What are the key factors to evaluate for NANX?
Nanophase Technologies Corporation (NANX) currently holds an AI score of 51/100, indicating moderate score. Key strength: Proprietary surface engineering technology. Primary risk to monitor: Competition from larger chemical companies with greater resources. This is not financial advice.
How frequently does NANX data refresh on this page?
NANX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NANX's recent stock price performance?
Recent price movement in Nanophase Technologies Corporation (NANX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary surface engineering technology. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NANX overvalued or undervalued right now?
Determining whether Nanophase Technologies Corporation (NANX) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NANX?
Before investing in Nanophase Technologies Corporation (NANX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Analyst consensus is based on limited coverage due to the company's size and OTC listing.
- OTC market data may be less reliable than data from major exchanges.